semaglutide vs tirzepatide hair loss has increasingly been reported among patients using GLP-1 and GIP agonists for weight loss. These include drugs like semaglutide, tirzepatide, liraglutide and others. Historically, this hair loss has been attributed Do Ozempic, Wegovy, Mounjaro &

GLP-1+GIP dual-agonists - such as tirzepatide - add a second mechanism: mimicking GIP (glucose-dependent insulinotropic polypeptide), which targets additional hormonal pathways involved in appetite and blood sugar regulation

This article walks through what high-quality studies tell us about stopping Wegovy, what happens to appetite and weight afterwards, and how clinicians typically approach maintenance and dose reduction in real-world practice

Some clinical trial data suggest that Tirzepatide at 7.5mg and higher doses may be associated with meaningful weight reduction in some patients

Patients receive DEXA scans to track fat mass, lean muscle, and changes in body weight, not just the number on the scale

Thrombocytopenia in lupus: baseline C3 as an independent risk factor for relapse